Roche is the producer of Avastin, and Novartis is the producer of Lucentis.
Notes on verification
Confirmed by original Italian regulatory source and multiple independent corroborating sources (FiercePharma, Biospace, RAPS). Roche is the developer/marketer of Avastin; Novartis holds European marketing rights to Lucentis (both drugs originally developed by Roche subsidiary Genentech). 'Producer' is standard shorthand used in Italian/EU regulatory contexts for Novartis's role. [tier=gold indep_score=0.838 clusters=4 claim_tier=notable | kind=empirical eligibility=high]
Sources
- Procedura di infrazione da parte dell'Autorità Antitrust (seed:health_and_medicine)
- https://www.fiercepharma.com/pharma/novartis-roche-fined-526m-france-for-alleged-lucentis-marketing-missteps (corroboration)
- https://www.raps.org/resource/french-regulator-and-roche-trade-blows-over-off-la.html (corroboration)
- https://www.biospace.com/novartis-ag-roche-accused-by-italy-of-eye-drug-cartel (corroboration)
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10845851 (corroboration)